The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes

• Main Authors: Jaikumkao K., Pongchaidecha A., Chatsudthipong V., Chattipakorn S., Chattipakorn N., Lungkaphin A.
• 格式: 雜誌
• 出版: 2017
• 在線閱讀: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85026376186&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/40092
• 機構: Chiang Mai University

© 2017 Elsevier Masson SAS Diabetic nephropathy (DN) is the leading cause of end stage renal disease (ESRD) worldwide. The early effective treatment of high plasma glucose could delay or prevent the onset of DN. Sodium-glucose cotransporter 2 (SGLT2) inhibitors are new target treatments for ameliora...